BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 20954872)

  • 1. Tenofovir disoproxil fumarate in the treatment of chronic hepatitis B.
    Jenh AM; Pham PA
    Expert Rev Anti Infect Ther; 2010 Oct; 8(10):1079-92. PubMed ID: 20954872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tenofovir for the treatment of hepatitis B virus.
    Jenh AM; Thio CL; Pham PA
    Pharmacotherapy; 2009 Oct; 29(10):1212-27. PubMed ID: 19792994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Therapy of chronic hepatitis B. Tenofovir--first choice in current EASL guidelines].
    MMW Fortschr Med; 2009 May; 151(22):38-9. PubMed ID: 19526965
    [No Abstract]   [Full Text] [Related]  

  • 4. Long-term outcome of tenofovir disoproxil fumarate use against hepatitis B in an HIV-coinfected cohort.
    Alvarez-Uria G; Ratcliffe L; Vilar J
    HIV Med; 2009 May; 10(5):269-73. PubMed ID: 19210695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of tenofovir disoproxil fumarate in antiretroviral therapy-naive and -experienced patients coinfected with HIV-1 and hepatitis B virus.
    Dore GJ; Cooper DA; Pozniak AL; DeJesus E; Zhong L; Miller MD; Lu B; Cheng AK; ;
    J Infect Dis; 2004 Apr; 189(7):1185-92. PubMed ID: 15031786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination of tenofovir and lamivudine versus tenofovir after lamivudine failure for therapy of hepatitis B in HIV-coinfection.
    Schmutz G; Nelson M; Lutz T; Sheldon J; Bruno R; von Boemmel F; Hoffmann C; Rockstroh J; Stoehr A; Wolf E; Soriano V; Berger F; Berg T; Carlebach A; Schwarze-Zander C; Schürmann D; Jaeger H; Mauss S
    AIDS; 2006 Oct; 20(15):1951-4. PubMed ID: 16988516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selection of an entecavir-resistant mutant despite prolonged hepatitis B virus DNA suppression, in a chronic hepatitis B patient with preexistent lamivudine resistance: successful rescue therapy with tenofovir.
    Leemans WF; Niesters HG; van der Eijk AA; Janssen HL; Schalm SW; de Man RA
    Eur J Gastroenterol Hepatol; 2008 Aug; 20(8):773-7. PubMed ID: 18617782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tenofovir: new indication. In chronic hepatitis B: beware bone toxicity.
    Prescrire Int; 2009 Jun; 18(101):116. PubMed ID: 19637428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tenofovir disoproxil fumarate in the treatment of chronic hepatitis B.
    Buti M; Homs M
    Expert Rev Gastroenterol Hepatol; 2012 Aug; 6(4):413-21. PubMed ID: 22928893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adefovir dipivoxil: new preparation. A third-line option in chronic hepatitis B.
    Prescrire Int; 2004 Feb; 13(69):4-7. PubMed ID: 15055205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tenofovir disoproxil fumarate exhibits strong antiviral effect in a patient with lamivudine-resistant severe hepatitis B reactivation.
    Van Bömmel F; Schernick A; Hopf U; Berg T
    Gastroenterology; 2003 Feb; 124(2):586-7. PubMed ID: 12557178
    [No Abstract]   [Full Text] [Related]  

  • 12. Antiviral treatment including entecavir plus tenofovir disoproxil fumarate for HBV reactivation following a rituximab-based regimen.
    Rago A; Lichtner M; Mecarocci S; Marocco R; Cenfra N; Belvisi V; Del Borgo C; Cimino G; Mastroianni CM
    Antivir Ther; 2010; 15(6):929-32. PubMed ID: 20834107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Six-year follow-up of hepatitis B surface antigen concentrations in tenofovir disoproxil fumarate treated HIV-HBV-coinfected patients.
    Thibault V; Stitou H; Desire N; Valantin MA; Tubiana R; Katlama C
    Antivir Ther; 2011; 16(2):199-205. PubMed ID: 21447869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic hepatitis B: a wider range of therapeutic options.
    Prescrire Int; 2007 Aug; 16(90):157-62. PubMed ID: 17724844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potency of tenofovir in chronic hepatitis B: mono or combination therapy?
    Reijnders JG; Janssen HL
    J Hepatol; 2008 Mar; 48(3):383-6. PubMed ID: 18191272
    [No Abstract]   [Full Text] [Related]  

  • 16. Tenofovir disoproxil fumarate for the treatment of hepatitis B infection.
    Adusumilli S
    Drugs Today (Barc); 2009 Sep; 45(9):679-85. PubMed ID: 19956809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New approaches to optimize treatment responses in chronic hepatitis B.
    Brunetto MR; Lok AS
    Antivir Ther; 2010; 15 Suppl 3():61-8. PubMed ID: 21041905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tenofovir for treatment of hepatitis B virus reactivation in patients with chronic GVHD.
    Hilgendorf I; Loebermann M; Borchert K; Junghanss C; Freund M; Schmitt M
    Bone Marrow Transplant; 2011 Sep; 46(9):1274-5. PubMed ID: 21151183
    [No Abstract]   [Full Text] [Related]  

  • 19. Tenofovir disoproxil fumarate: in chronic hepatitis B.
    Perry CM; Simpson D
    Drugs; 2009 Nov; 69(16):2245-56. PubMed ID: 19852527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two-year data released on Viread for chronic hepatitis B.
    AIDS Patient Care STDS; 2008 Nov; 22(11):921. PubMed ID: 19025487
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.